Carmat: share price rises, scientific forum a success

(CercleFinance.com) - With gains of over 12%, Carmat's shares were one of the strongest performers on the Paris Bourse on Tuesday, following the "success" of its scientific event held last week.



Not content with the "marked interest" shown by the French and international medical community in its Aeson artificial heart, the company claims to have observed a "high" level of intention to use among participants.

The "Aeson European User Meeting" forum - held on November 21 and 22 in Chantilly, north of Paris - brought together over 100 European cardiology experts.

These surgeons, anaesthetists, resuscitators, nurses and specialized distributors represented 41 hospitals and 10 countries (France, Germany, Italy, Spain, Poland, the Netherlands, Serbia, Slovenia, Macedonia and Israel).

According to Carmat, all the centers present confirmed that they are planning to have implants in 2025, which the medtech company expects to see strong sales growth in the coming months.

All this feedback leads me to believe that implantations will increase in centers that are already active, and that many of the 30 or so trained hospitals that have not yet performed their first implantations will take the plunge in the near future", commented Stéphane Piat, Carmat's CEO.

Copyright (c) 2024 CercleFinance.com. All rights reserved.